{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:51:47Z","timestamp":1790941907379,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.cgh.2005.12.002","type":"journal-article","created":{"date-parts":[[2006,2,8]],"date-time":"2006-02-08T13:25:25Z","timestamp":1139405125000},"page":"203-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":174,"title":["Safety of Celecoxib in Patients With Ulcerative Colitis in Remission: A Randomized, Placebo-Controlled, Pilot Study"],"prefix":"10.1016","volume":"4","author":[{"given":"William J.","family":"Sandborn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Stenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rn","family":"Brynskov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin G.","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina M.","family":"Steidle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery L.","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery D.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J.","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2005.12.002_bib1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nature New Biol"},{"key":"10.1016\/j.cgh.2005.12.002_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/1529-0131(200001)43:1<4::AID-ANR2>3.0.CO;2-V","article-title":"Basic biology and clinical application of specific cyclooxygenase-2 inhibitors","volume":"43","author":"Crofford","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cgh.2005.12.002_bib3","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(99)02332-6","article-title":"Celecoxib versus diclofenac in long-term management of rheumatoid arthritis","volume":"354","author":"Emery","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2005.12.002_bib4","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1001\/jama.282.20.1921","article-title":"Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis","volume":"282","author":"Simon","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2005.12.002_bib5","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2005.12.002_bib6","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2005.12.002_bib7","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1053\/gast.2003.50054","article-title":"Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use","volume":"124","author":"Laine","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2005.12.002_bib8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00005792-197609000-00004","article-title":"The extra-intestinal complications of Crohn\u2019s disease and ulcerative colitis","volume":"55","author":"Greenstein","year":"1976","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cgh.2005.12.002_bib9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/pgmj.57.667.297","article-title":"Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs","volume":"57","author":"Rampton","year":"1981","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.cgh.2005.12.002_bib10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7326\/0003-4819-107-4-513","article-title":"Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease","volume":"107","author":"Kaufmann","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2005.12.002_bib11","first-page":"160","article-title":"NSAID-induced irreversible exacerbation of ulcerative colitis","volume":"15","author":"Hovde","year":"1992","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2005.12.002_bib12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/gut.40.5.619","article-title":"Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease","volume":"40","author":"Evans","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2005.12.002_bib13","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/j.1572-0241.2000.02262.x","article-title":"Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease","volume":"95","author":"Felder","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2005.12.002_bib14","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1572-0241.2002.05608.x","article-title":"Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease","volume":"97","author":"Mahadevan","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2005.12.002_bib15","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1365-2036.2003.01596.x","article-title":"An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia","volume":"17","author":"Reinisch","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2005.12.002_bib16","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/j.1572-0241.2001.03730.x","article-title":"Exacerbation of inflammatory bowel disease associated with use of celecoxib","volume":"96","author":"Bonner","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2005.12.002_bib17","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1111\/j.1572-0241.2002.07142.x","article-title":"Exacerbation of Crohn\u2019s colitis with severe colonic hemorrhage in a patient on rofecoxib","volume":"97","author":"Gornet","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2005.12.002_bib18","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1365-2036.2004.01907.x","article-title":"Rofecoxib and early relapse of inflammatory bowel disease","volume":"19","author":"Biancone","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2005.12.002_bib19","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00054725-200407000-00005","article-title":"The spectrum of gastrointestinal toxicity and effect on disease activity of selective cyclooxygenase-2 inhibitors in patients with inflammatory bowel disease","volume":"10","author":"Matuk","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2005.12.002_bib20","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study","volume":"317","author":"Schroeder","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2005.12.002_bib21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/gut.47.3.404","article-title":"A reproducible grading scale for histological assessment of inflammation in ulcerative colitis","volume":"47","author":"Geboes","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2005.12.002_bib22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0016-5085(98)70196-9","article-title":"Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease","volume":"115","author":"Singer","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2005.12.002_bib23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1365-2036.2003.01519.x","article-title":"Non-steroidal anti-inflammatory drugs, aspirin and newly diagnosed colitis","volume":"17","author":"Gleeson","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2005.12.002_bib24","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2005.12.002_bib25","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2005.12.002_bib26","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1056\/NEJM200506233522519","article-title":"Cardiovascular risk associated with celecoxib","volume":"352","author":"Brophy","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356505011080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356505011080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:55:54Z","timestamp":1761540954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356505011080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S1542356505011080"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2005.12.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.10195.467688","asserted-by":"object"}]},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of Celecoxib in Patients With Ulcerative Colitis in Remission: A Randomized, Placebo-Controlled, Pilot Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2005.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Gastroenterological Association Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}